Published in Science on September 06, 2001
How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol (2007) 10.98
Structural basis of integrin regulation and signaling. Annu Rev Immunol (2007) 8.60
Negative Staining and Image Classification - Powerful Tools in Modern Electron Microscopy. Biol Proced Online (2004) 6.14
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature (2004) 5.87
Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol Biol Cell (2002) 4.27
The integrins. Genome Biol (2007) 3.72
Cell spreading and focal adhesion dynamics are regulated by spacing of integrin ligands. Biophys J (2007) 3.57
Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell (2008) 3.54
Demonstration of catch bonds between an integrin and its ligand. J Cell Biol (2009) 3.26
Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J (2003) 2.99
The Structural Biology Center 19ID undulator beamline: facility specifications and protein crystallographic results. J Synchrotron Radiat (2005) 2.62
Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol (2011) 2.58
beta8 integrins are required for vascular morphogenesis in mouse embryos. Development (2002) 2.55
Recreation of the terminal events in physiological integrin activation. J Cell Biol (2010) 2.48
Structure and mechanics of integrin-based cell adhesion. Curr Opin Cell Biol (2007) 2.48
The mechanisms and dynamics of (alpha)v(beta)3 integrin clustering in living cells. J Cell Biol (2005) 2.46
The structure of the integrin alphaIIbbeta3 transmembrane complex explains integrin transmembrane signalling. EMBO J (2009) 2.45
Force measurements of the alpha5beta1 integrin-fibronectin interaction. Biophys J (2003) 2.27
Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov (2010) 2.27
A specific interface between integrin transmembrane helices and affinity for ligand. PLoS Biol (2004) 2.26
The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood (2008) 2.22
The vessel wall and its interactions. Blood (2008) 2.17
Linking integrin conformation to function. J Cell Sci (2009) 2.15
Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest (2004) 2.06
A novel variant of the immunoglobulin fold in surface adhesins of Staphylococcus aureus: crystal structure of the fibrinogen-binding MSCRAMM, clumping factor A. EMBO J (2002) 2.06
Integrin structures and conformational signaling. Curr Opin Cell Biol (2006) 2.03
Integrin activation takes shape. J Cell Biol (2002) 2.02
Three-dimensional EM structure of the ectodomain of integrin {alpha}V{beta}3 in a complex with fibronectin. J Cell Biol (2005) 1.97
Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization. Structure (2004) 1.97
Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand. Proc Natl Acad Sci U S A (2003) 1.93
Three-dimensional model of the human platelet integrin alpha IIbbeta 3 based on electron cryomicroscopy and x-ray crystallography. Proc Natl Acad Sci U S A (2002) 1.93
Integrin inside-out signaling and the immunological synapse. Curr Opin Cell Biol (2011) 1.89
FRET detection of cellular alpha4-integrin conformational activation. Biophys J (2003) 1.88
Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation. Anticancer Agents Med Chem (2010) 1.87
Importance of force linkage in mechanochemistry of adhesion receptors. Biochemistry (2006) 1.87
Vascular development of the brain requires beta8 integrin expression in the neuroepithelium. J Neurosci (2005) 1.85
Ancient origin of the integrin-mediated adhesion and signaling machinery. Proc Natl Acad Sci U S A (2010) 1.81
The rbmBCDEF gene cluster modulates development of rugose colony morphology and biofilm formation in Vibrio cholerae. J Bacteriol (2007) 1.78
Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest (2005) 1.76
Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression. Proc Natl Acad Sci U S A (2005) 1.72
Anti-integrin monoclonal antibodies. J Cell Sci (2009) 1.72
Structure of an integrin with an alphaI domain, complement receptor type 4. EMBO J (2009) 1.70
Crystal structure of the complete integrin alphaVbeta3 ectodomain plus an alpha/beta transmembrane fragment. J Cell Biol (2009) 1.68
Synapses: sites of cell recognition, adhesion, and functional specification. Annu Rev Biochem (2007) 1.65
The tail of integrin activation. Trends Biochem Sci (2011) 1.62
Distinct ligand binding sites in integrin alpha3beta1 regulate matrix adhesion and cell-cell contact. J Cell Biol (2003) 1.62
Why integrin as a primary target for imaging and therapy. Theranostics (2011) 1.61
How the headpiece hinge angle is opened: New insights into the dynamics of integrin activation. J Cell Biol (2006) 1.60
Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus. J Virol (2002) 1.60
New PI(4,5)P2- and membrane proximal integrin-binding motifs in the talin head control beta3-integrin clustering. J Cell Biol (2009) 1.58
Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat Struct Mol Biol (2009) 1.58
Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium. JACC Cardiovasc Imaging (2008) 1.57
Requirement of alpha and beta subunit transmembrane helix separation for integrin outside-in signaling. Blood (2007) 1.52
Crystal structure of α5β1 integrin ectodomain: atomic details of the fibronectin receptor. J Cell Biol (2012) 1.52
Regulation of integrin activity and signalling. Biochim Biophys Acta (2009) 1.51
Integrin bidirectional signaling: a molecular view. PLoS Biol (2004) 1.49
Intersubunit signal transmission in integrins by a receptor-like interaction with a pull spring. Proc Natl Acad Sci U S A (2004) 1.49
Flexibility of the adenovirus fiber is required for efficient receptor interaction. J Virol (2003) 1.49
Regulation of integrin affinity on cell surfaces. EMBO J (2011) 1.47
Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin. Blood (2012) 1.46
Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers. Mol Imaging Biol (2006) 1.46
Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding. J Cell Biol (2005) 1.44
Potentiation of the ligand-binding activity of integrin alpha3beta1 via association with tetraspanin CD151. Proc Natl Acad Sci U S A (2005) 1.44
Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A (2003) 1.42
A specific alpha5beta1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation. J Cell Sci (2004) 1.42
Solution structures of the cytoplasmic tail complex from platelet integrin alpha IIb- and beta 3-subunits. Proc Natl Acad Sci U S A (2002) 1.41
The beta-tail domain (betaTD) regulates physiologic ligand binding to integrin CD11b/CD18. Blood (2006) 1.40
Intermediate-affinity LFA-1 binds alpha-actinin-1 to control migration at the leading edge of the T cell. EMBO J (2007) 1.39
Transmembrane and cytoplasmic domains in integrin activation and protein-protein interactions (review). Mol Membr Biol (2008) 1.39
Two-dimensional kinetics regulation of alphaLbeta2-ICAM-1 interaction by conformational changes of the alphaL-inserted domain. J Biol Chem (2005) 1.38
Rolling on E- or P-selectin induces the extended but not high-affinity conformation of LFA-1 in neutrophils. Blood (2010) 1.37
Complete integrin headpiece opening in eight steps. J Cell Biol (2013) 1.37
Cell adhesion strength is controlled by intermolecular spacing of adhesion receptors. Biophys J (2010) 1.37
Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation. Proc Natl Acad Sci U S A (2004) 1.36
Integrin targeted therapeutics. Theranostics (2011) 1.36
Activation of integrin beta-subunit I-like domains by one-turn C-terminal alpha-helix deletions. Proc Natl Acad Sci U S A (2004) 1.35
Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis (2002) 1.34
Evolution of distinct EGF domains with specific functions. Protein Sci (2005) 1.33
Observing force-regulated conformational changes and ligand dissociation from a single integrin on cells. J Cell Biol (2012) 1.33
Requirement of open headpiece conformation for activation of leukocyte integrin alphaXbeta2. Proc Natl Acad Sci U S A (2010) 1.32
Nanolithographic control of the spatial organization of cellular adhesion receptors at the single-molecule level. Nano Lett (2011) 1.30
Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIA. Blood (2007) 1.30
Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening. Blood (2010) 1.29
Evidence that monoclonal antibodies directed against the integrin beta subunit plexin/semaphorin/integrin domain stimulate function by inducing receptor extension. J Biol Chem (2004) 1.29
Pathogenic hantaviruses bind plexin-semaphorin-integrin domains present at the apex of inactive, bent alphavbeta3 integrin conformers. Proc Natl Acad Sci U S A (2005) 1.29
β1 integrin regulates Arg to promote invadopodial maturation and matrix degradation. Mol Biol Cell (2013) 1.29
Integrin alpha IIb beta 3 in a membrane environment remains the same height after Mn2+ activation when observed by cryoelectron tomography. J Mol Biol (2008) 1.29
Tests of the extension and deadbolt models of integrin activation. J Biol Chem (2007) 1.28
Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature. Brain Pathol (2008) 1.28
Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1. J Biomed Biotechnol (2010) 1.27
Focal adhesions are sites of integrin extension. J Cell Biol (2010) 1.26
Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma. J Leukoc Biol (2007) 1.25
Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. Am J Pathol (2009) 1.25
Molecular interplay between endostatin, integrins, and heparan sulfate. J Biol Chem (2009) 1.25
Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis. Proc Natl Acad Sci U S A (2004) 1.21
Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin alpha4beta1. Mol Biol Cell (2005) 1.21
Structural diversity in integrin/talin interactions. Structure (2010) 1.20
Integrin clipping: a novel adhesion switch? J Cell Biochem (2004) 1.19
Expression and genomic analysis of midasin, a novel and highly conserved AAA protein distantly related to dynein. BMC Genomics (2002) 1.18
The emergence of integrins: a personal and historical perspective. Matrix Biol (2004) 1.18
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins (1991) 36.69
Protein structure comparison by alignment of distance matrices. J Mol Biol (1993) 34.74
Integrins: versatility, modulation, and signaling in cell adhesion. Cell (1992) 34.06
The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell (1995) 7.66
Cation-pi interactions in structural biology. Proc Natl Acad Sci U S A (1999) 6.88
Ligand binding to integrins. J Biol Chem (2000) 4.94
Structural basis of collagen recognition by integrin alpha2beta1. Cell (2000) 4.84
Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell (1995) 4.73
Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J Biol Chem (1996) 4.45
Integrin structure. Biochem Soc Trans (2000) 3.49
Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure (1995) 3.15
The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest (1999) 2.88
Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol (2001) 2.86
Molecular interactions in cell adhesion complexes. Curr Opin Cell Biol (1997) 2.79
Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell (1996) 2.40
Regulation of integrin alpha 5 beta 1-fibronectin interactions by divalent cations. Evidence for distinct classes of binding sites for Mn2+, Mg2+, and Ca2+. J Biol Chem (1995) 2.35
Leukocyte adhesion molecules deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol Rev (1990) 2.30
Domains in plexins: links to integrins and transcription factors. Trends Biochem Sci (1999) 2.23
The molecular structure of cell adhesion molecules. Annu Rev Biochem (1997) 2.18
Examination of the platelet membrane glycoprotein IIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy. J Biol Chem (1992) 2.18
Integrin associated proteins. Curr Opin Cell Biol (1998) 2.17
A novel divalent cation-binding site in the A domain of the beta 2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell (1993) 2.15
An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain. J Biol Chem (2000) 1.84
Long range propagation of conformational changes in integrin alpha IIb beta 3. J Biol Chem (1993) 1.73
Electron microscopy and structural model of human fibronectin receptor. EMBO J (1988) 1.69
Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures. J Cell Biol (1998) 1.67
Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J Biol Chem (1991) 1.67
Calcium regulation of the platelet membrane glycoprotein IIb-IIIa complex. J Biol Chem (1985) 1.56
The actin cytoskeleton regulates LFA-1 ligand binding through avidity rather than affinity changes. J Biol Chem (1999) 1.56
Effects of ligand-mimetic peptides Arg-Gly-Asp-X (X = Phe, Trp, Ser) on alphaIIbbeta3 integrin conformation and oligomerization. Biochemistry (1999) 1.43
Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin alpha5 beta1. Biochem J (1998) 1.29
Transmembrane-truncated alphavbeta3 integrin retains high affinity for ligand binding: evidence for an 'inside-out' suppressor? Biochem J (1998) 1.27
Integrin alphaIIb beta3 reconstituted into lipid bilayers is nonclustered in its activated state but clusters after fibrinogen binding. Biochemistry (1997) 1.25
Genetic analysis of integrin function in man: LAD-1 and other syndromes. Matrix Biol (2000) 1.22
Platelet membrane glycoprotein IIb-IIIa complex incorporated into phospholipid vesicles. Preparation and morphology. J Biol Chem (1985) 1.19
Platelet integrin GPIIb/IIIa: structure-function correlations. An update and lessons from other integrins. Proc Soc Exp Biol Med (1999) 1.15
An allosteric Ca2+ binding site on the beta3-integrins that regulates the dissociation rate for RGD ligands. J Biol Chem (1996) 1.14
Expression of a soluble and functional form of the human beta 2 integrin CD11b/CD18. Proc Natl Acad Sci U S A (1991) 1.08
Defining extracellular integrin alpha-chain sites that affect cell adhesion and adhesion strengthening without altering soluble ligand binding. Mol Biol Cell (1997) 0.99
Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell (1997) 16.78
Crystal structure of trp repressor/operator complex at atomic resolution. Nature (1988) 7.34
The crystal structure of the bacterial chaperonin GroEL at 2.8 A. Nature (1994) 6.72
X-ray structure determination of fully hydrated L alpha phase dipalmitoylphosphatidylcholine bilayers. Biophys J (1996) 5.60
Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood (1989) 5.08
Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell (1995) 4.73
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest (2000) 4.36
Effects of synthetic micro- and nano-structured surfaces on cell behavior. Biomaterials (1999) 4.32
Survival by time of day of hemodialysis in an elderly cohort. JAMA (2001) 4.09
Measurement of chain tilt angle in fully hydrated bilayers of gel phase lecithins. Biophys J (1993) 4.08
A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity (1996) 4.03
Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin. J Cell Biol (1985) 3.77
Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/CD18-mediated event and enhanced efficiency in physiological direction. J Clin Invest (1991) 3.67
The three-dimensional structure of trp repressor. Nature (1985) 3.26
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology (2001) 3.25
The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science (1999) 3.23
Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J Clin Invest (1983) 3.23
Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure (1995) 3.15
Relationship of a putative receptor protein kinase from maize to the S-locus glycoproteins of Brassica. Nature (1990) 3.11
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res (2001) 3.01
Subcellular localization of the large subunit of Mo1 (Mo1 alpha; formerly gp 110), a surface glycoprotein associated with neutrophil adhesion. J Clin Invest (1984) 3.01
Taking MAD to the extreme: ultrafast protein structure determination. Acta Crystallogr D Biol Crystallogr (1999) 2.85
Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet (1987) 2.81
N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. J Med Chem (1999) 2.76
Purification and characterization of trp aporepressor. Proc Natl Acad Sci U S A (1983) 2.70
Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene (2007) 2.68
Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulators. J Med Chem (1995) 2.68
Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis (1984) 2.67
Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci U S A (2001) 2.62
Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence. J Clin Invest (1984) 2.57
Cell-cell interaction and polarity of epithelial cells: specific perturbation using a monoclonal antibody. Cell (1983) 2.56
Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A. Proteins (2004) 2.51
Deficiency of a granulocyte-membrane glycoprotein (gp150) in a boy with recurrent bacterial infections. N Engl J Med (1982) 2.47
Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mo1 deficiency. Effects of cell activation on Mo1/LFA-1 surface expression in normal and deficient leukocytes. J Clin Invest (1984) 2.46
Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J Immunol (1986) 2.45
Structure of Thermotoga maritima stationary phase survival protein SurE: a novel acid phosphatase. Structure (2001) 2.43
Sensorimotor changes and functional performance in patients with knee osteoarthritis. Ann Rheum Dis (1997) 2.39
The crystal structure of trp aporepressor at 1.8 A shows how binding tryptophan enhances DNA affinity. Nature (1987) 2.34
Deficiency of a surface membrane glycoprotein (Mo1) in man. J Clin Invest (1984) 2.29
Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A (2000) 2.23
Determinants of repressor/operator recognition from the structure of the trp operator binding site. Nature (1994) 2.22
Synthetic nano-scale fibrous extracellular matrix. J Biomed Mater Res (1999) 2.21
The way forward for hydrotherapy. Br J Rheumatol (1993) 2.15
A novel divalent cation-binding site in the A domain of the beta 2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell (1993) 2.15
p150/95, Third member of the LFA-1/CR3 polypeptide family identified by anti-Leu M5 monoclonal antibody. Eur J Immunol (1985) 2.14
Cause of death in rheumatoid arthritis. Br J Rheumatol (1984) 2.12
Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med (1999) 2.11
The clinical features of chronic vitamin deficiency. A therapeutic trial in geriatric hospital patients. Gerontol Clin (Basel) (1968) 2.09
Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry. EMBO J (1998) 2.06
Can patients benefit from reading copies of their doctors' letters about them? Br Med J (Clin Res Ed) (1986) 2.04
The three-dimensional crystal structure of cholera toxin. J Mol Biol (1995) 2.03
Nanoscale topography of the basement membrane underlying the corneal epithelium of the rhesus macaque. Cell Tissue Res (2000) 2.03
Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest (1999) 2.03
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med (2001) 2.00
Archaeal surface layer proteins contain beta propeller, PKD, and beta helix domains and are related to metazoan cell surface proteins. Structure (2002) 2.00
Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol (1998) 2.00
Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polarized fashion. J Cell Biol (1993) 1.96
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) (2001) 1.96
Characteristics and crystal structure of bacterial inosine-5'-monophosphate dehydrogenase. Biochemistry (1999) 1.93
Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc Natl Acad Sci U S A (2001) 1.92
Two distinct cell-binding domains in laminin can independently promote nonneuronal cell adhesion and spreading. J Cell Biol (1987) 1.92
A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1. Proc Natl Acad Sci U S A (1998) 1.91
Atomic resolution imaging of a carbon nanotube from diffraction intensities. Science (2003) 1.90
Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan. Nat Struct Biol (2000) 1.89
Neutrophil migration across a cultured epithelial monolayer elicits a biphasic resistance response representing sequential effects on transcellular and paracellular pathways. J Cell Biol (1992) 1.89
Cytokinin Biochemistry in Relation to Leaf Senescence: IV. Cytokinin Metabolism in Soybean Explants. Plant Physiol (1988) 1.87
Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis (1984) 1.86
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) (2005) 1.84
Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol (2000) 1.84
Nanoscale topography of the corneal epithelial basement membrane and Descemet's membrane of the human. Cornea (2000) 1.84
An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain. J Biol Chem (2000) 1.84
Lung cancer among Chinese women. Int J Cancer (1987) 1.83
Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population. Diabetologia (2009) 1.83
Constitutive and stimulus-induced phosphorylation of CD11/CD18 leukocyte adhesion molecules. J Cell Biol (1989) 1.82
Purified N-cadherin is a potent substrate for the rapid induction of neurite outgrowth. J Cell Biol (1990) 1.82
Lymphoedema of the limbs as an extra-articular feature of rheumatoid arthritis. Ann Rheum Dis (1990) 1.79
Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue. Science (1990) 1.77
Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J Clin Invest (1986) 1.76
Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors. Dev Biol (1996) 1.75
Analysis of distribution of bases in the coding sequences by a diagrammatic technique. Nucleic Acids Res (1991) 1.75
Crystal structure of two CD46 domains reveals an extended measles virus-binding surface. EMBO J (1999) 1.73
The long-term effects of treating rheumatoid arthritis. J R Coll Physicians Lond (1983) 1.70
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials. Ann Rheum Dis (2007) 1.68
Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol (2001) 1.68
Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures. J Cell Biol (1998) 1.67
Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases. Ann Rheum Dis (1984) 1.66
Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis (1992) 1.65
Frequency of occurrence, mode of development, and significance or rice bodies in rheumatoid joints. Ann Rheum Dis (1982) 1.62
Joint counts in routine practice. Rheumatology (Oxford) (2003) 1.62
Phosphoinositides in mitogenesis: neomycin inhibits thrombin-stimulated phosphoinositide turnover and initiation of cell proliferation. Cell (1985) 1.62
Disruption of the keratin filament network during epithelial cell division. EMBO J (1982) 1.61
Human Hsp70 molecular chaperone binds two calcium ions within the ATPase domain. Structure (1997) 1.60
Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) (2006) 1.58